CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
002915 Zhejiang Zhongxin Fluoride Materials
- 21.37
- +1.94+9.98%
Market Closed Apr 30 15:00 CST
6.96BMarket Cap-37.62P/E (TTM)
21.37High20.00Low809.44KlotVolume21.37Open19.43Pre Close1.69BTurnover28.08%Turnover RatioLossP/E (Static)325.47MShares21.3752wk High5.34P/B6.16BFloat Cap8.5752wk Low21.37Limit Up288.31MShs Float27.29Historical High17.49Limit Down7.05%Amplitude3.00Historical Low--Dividend TTM20.92Avg Price399.63KlotAsk--Div YieldTTM100Lot Size269.66KlotBid
Zhejiang Zhongxin Fluoride Materials News
On the Dragon and Tiger List, Zhejiang Zhongxin Fluoride Materials had a turnover ratio of 33.66% today, with net buy of 0.106 billion yuan by three speculators.
Zhejiang Zhongxin Fluoride Materials (002915.SZ) rose 5.24% today, with a Turnover Ratio of 33.66% and a transaction amount of 1.697 billion yuan. Data from the dragon and tiger list shows that the retail investor "Stock Raising Family" ranked first in buying, with a net purchase of 66.1558 million yuan; "Leader Zhang" ranked second, with a net purchase of 19.373 million yuan; "King of Yue Road" ranked fourth, with a net purchase of 20.3995 million yuan. Three institutions bought 72.7108 million yuan and sold 42.5105 million yuan, resulting in a net purchase of 30.2 million yuan. (Ge Long Hui)
Zhejiang Zhongxin Fluoride Materials Co.,Ltd's (SZSE:002915) Shares Climb 28% But Its Business Is Yet to Catch Up
Zhongxin Fluoride Materials: 2024 Annual Report Summary
Zhongxin Fluoride: Report for the first quarter of 2025
Zhongxin Fluoride Materials: 2024 Annual Report
Zhejiang Zhongxin Fluoride Materials (002915.SZ): The net income for the first quarter is 3.1155 million yuan, a year-on-year increase of 22.00%.
Gelonghui reported on April 21 that Zhejiang Zhongxin Fluoride Materials (002915.SZ) announced its first quarter report for 2025. In the first quarter, the company achieved revenue of 0.356 billion yuan, a year-on-year increase of 11.97%; the net income attributable to shareholders of the listed company was 3.1155 million yuan, a year-on-year increase of 22.00%; the net income attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 2.6449 million yuan, a year-on-year increase of 76.62%; basic EPS was 0.0096 yuan.
Zhejiang Zhongxin Fluoride MaterialsLtd (SZSE:002915 Shareholders Incur Further Losses as Stock Declines 12% This Week, Taking Three-year Losses to 29%
Zhejiang Zhongxin Fluoride Materials (002915.SZ): has already established a production capacity of 5,000 tons for the core intermediate PEEK – DFBP.
Gelonghui, March 26丨Zhejiang Zhongxin Fluoride Materials (002915.SZ) stated on the investor interaction platform that the company is targeting the demand for high-performance Lightweight materials and has established a production capacity of 5,000 tons of PEEK core intermediates – DFBP. Additionally, it has developed an integrated Industry Chain around DFBP, including fluorobenzene, 4-fluorobenzoyl chloride, hydrofluoric acid, and fluorite. In the face of a rapidly growing Lightweight materials market, the company will continue to increase market development and resource investment in this field while also collaborating with end users on joint technology development to meet their needs for customized raw materials.
Zhejiang Zhongxin Fluoride Materials (002915.SZ): Currently, the annual production of sulfuric acid is 0.2 million tons, mainly for self-use.
Gelonghui reported on March 25 that Zhejiang Zhongxin Fluoride Materials (002915.SZ) stated on the investor interaction platform that the company currently has an annual production of 200,000 tons of sulfuric acid, mainly for self-use. The actual output will be dynamically adjusted according to the production demand of anhydrous hydrofluoric acid. For specific operational conditions, please pay attention to the periodic reports.
Zhejiang Zhongxin Fluoride Materials (002915.SZ) products are currently not directly applied in marine-related fields.
Gelonghui reported on March 17 that Zhejiang Zhongxin Fluoride Materials (002915.SZ) stated on the investor interactive platform that the company's products have not yet been directly applied in marine-related fields.
Zhejiang Zhongxin Fluoride Materials (002915.SZ): Focused on developing new types of Electrolyte products.
On March 4, Gelonghui reported that Zhejiang Zhongxin Fluoride Materials (002915.SZ) stated on the investor interaction platform that the company adheres to technology leadership, deeply engaging in the field of fluorochemistry, and is committed to building core competencies with competitive advantages in the industry. In the field of fluoride new energy materials, the company is concentrating its efforts on developing new electrolyte products, and related research and development projects are progressing in an orderly manner. For specific research and development progress, please pay attention to the company's regular reports.
Zhejiang Zhongxin Fluoride Materials (002915.SZ): An integrated PEEK core raw material industry layout has been established.
On March 4th, Gelonghui reported that Zhejiang Zhongxin Fluoride Materials (002915.SZ) stated on the investor interaction platform that in terms of polyether ether ketone (PEEK), the company has established an integrated industrial layout for PEEK core raw materials. Among them, the DFBP product has received quality certification from multiple domestic and foreign customers, and has already obtained bulk Orders from some domestic and foreign clients. As DFBP is the core monomer for synthesizing PEEK, its demand benefits, on one hand, from the gradual expansion of traditional applications in medical instruments materials and electronic and electrical materials, and on the other hand, from the expansion of applications in emerging fields for Lightweight materials. The company will closely monitor the situation.
Is Zhejiang Zhongxin Fluoride MaterialsLtd (SZSE:002915) A Risky Investment?
Zhongxin Fluoride: 2024 Annual Results Forecast
Zhejiang Zhongxin Fluoride Materials (002915.SZ): Expected pre-loss of 0.18 billion yuan to -0.2 billion yuan for the 2024 fiscal year.
Gelonghui, January 17丨Zhejiang Zhongxin Fluoride Materials (002915.SZ) announced the annual performance forecast for 2024. The net income attributable to shareholders of the listed company is expected to be a loss of 0.18 billion yuan – 0.2 billion yuan, compared to a loss of 0.188 billion yuan in the same period last year; the net income after deducting non-recurring gains and losses is expected to be a loss of 0.167 billion yuan – 0.185 billion yuan, compared to a loss of 0.179 billion yuan in the same period last year; the basic EPS is expected to be a loss of 0.5506 yuan/share – 0.6118 yuan/share; revenue is expected to be 1.4 billion yuan – 1.42 billion yuan. During the reporting period, the company increased its efforts to expand the market for intermediate business and fluorine fine chemical business.
Retail Investors Invested in Zhejiang Zhongxin Fluoride Materials Co.,Ltd (SZSE:002915) Copped the Brunt of Last Week's CN¥1.0b Market Cap Decline
Investors in Zhejiang Zhongxin Fluoride MaterialsLtd (SZSE:002915) From Three Years Ago Are Still Down 44%, Even After 10% Gain This Past Week
10 consecutive trading limits! The big monster stock makes a comeback.
What exactly are you speculating about?
Zhejiang Zhongxin Fluoride Materials (002915.SZ): The company's pharmaceutical intermediates can be used in the field of CRO (Contract Research Outsourcing) pharmaceutical research and development.
Gelonghui October 18th: Zhejiang Zhongxin Fluoride Materials (002915.SZ) stated on the investor interaction platform that the company's pharmaceutical intermediates can be used in the field of CRO (Contract Research Outsourcing) pharmaceutical research and development. Pharmaceutical intermediates are important chemical raw materials in the drug synthesis process, playing a key role in the research and development of new drugs. Currently, the company has formed pharmaceutical intermediates represented by the 2,3,4,5-tetrafluorobenzene series, nanosar acid, and trifluoroacetic acid series. It has a provincial-level small and medium-sized enterprise technology center, a provincial-level enterprise research institute - Zhejiang Zhongxin Fluoride Chemicals and New Materials Research Institute, dedicated to pharmaceutical intermediates.
Zhongxin Fluoride: Report for the third quarter of 2024